International Journal of Medical Science and Clinical invention 2018-12-12T07:57:14+00:00 Valley International Open Journal Systems <p style="text-align: justify;"><strong>International Journal of Medical Science and Clinical&nbsp;invention </strong></p> <p style="text-align: justify;">IJMSCI is an international, peer-reviewed open access journal of medicine published in English. The journal's publisher is the Valley International</p> <p style="text-align: justify;">The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of medical sciences. The Journal welcomes articles of general interest to audiences of medical researchers especially when they contain new information. Articles of clinical evaluation of drugs and other therapies,&nbsp;epidemiology&nbsp;studies in general population, studies on pathogenic organisms and toxic materials, toxicities and adverse effects of therapeutics are welcome.</p> <p style="text-align: justify;">When written in language other than English and has not been propagated in any international information services (abstract journals), secondary publication of the article is negotiable.</p> The Use of Mobile Technology among Healthcare providers (HcPs) for improved health outcomes in Sub-Saharan Africa (SSA): A narrative review 2018-12-09T13:54:40+00:00 Annah Rufu (PhD fellow) Kudakwashe Chitindingu (PhD supervisor) <p><strong>Aim:</strong>The study reviewed literature for mobile technology (mHealth) usage by frontline healthcare providers (HcPs) in SSA to explore opportunities and constraints for improving health outcomes.<strong>&nbsp;</strong></p> <p><strong>Background:</strong>Resource-constrained countries engage the services of HcPs as conduits of healthcare service between the health centre and the clients. Despite the increasing number of health mHealth tools that have been developed to support HcPs, few of these applications have been rigorously evaluated and even fewer have been brought to scale to improve health outcomes.&nbsp;</p> <p><strong>Methods:</strong>The study did a narrative review of 24 peer-reviewed literature (in English) 2000 to 2018 from health, social science, and computer engineering databases, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines.</p> <p><strong>Results:</strong>HcPs in SSA have used mHealth with encouraging health outcomes particularly in sexual and reproductive health including HIV. Literature reviewed that projects are mostly concentrating on improving health governance, learning and implementation of health benchmarks and guidelines. Of the researches that evaluated program outcomes, evidence is that mHealth is handy to HcP in improving quality of healthcare, program monitoring capacity and improved service efficiency.</p> <p><strong>Conclusion:</strong>Evidence from grey literature suggests encouraging opportunities for use of mHealth to improve the quality of health outcomes. A positive trend towards using mHealth that lead to positive health and programming outcomes through operational improvements and innovative intervention designs has been observed. However, SSA leaders need to address programmatic and research gaps as they advance the use and assessment of mobile technology tools for HcPs.</p> <p>&nbsp;</p> <p>&nbsp;</p> 2018-12-01T00:00:00+00:00 ##submission.copyrightStatement## Healthcare Providers’ perceptions on desired attributes for mobile health Apps: A qualitative evidence review 2018-12-09T13:56:40+00:00 Annah Rufu (PhD fellow) Kudakwashe Chitindingu (PhD supervisor) <p><strong>Aim:</strong>This review explores perceptions of healthcare providers (HcPs) on desirable attributes for mobile-health Applications.<strong>&nbsp;</strong></p> <p><strong>Background:</strong>Studies in all study settings have reported encouraging potential for Mobile-health (mHealth) technologies in improving health outcomes. However, literature bears little evidence of such capability up scale. Paying little attention to technology user acceptability as one of the key drivers of innovation adoption has been widely cited as a notable mHealth limitation.&nbsp;</p> <p><strong>Methods:</strong>This systematic review navigated through English authored peer-reviewed publications from health, computer engineering and social science repositories as guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search was confined between January 2014 and October 2018 thus, yielding <strong>eleven (11)</strong> complete-text publications.</p> <p><strong>Results:</strong>HcPs in the reviewed literature have used mobile-technology applications for monitoring and management of sexual (18.2%), reproductive &amp; maternal health (9.1%), HIV (45.5%), Malaria (9.1%) and other chronic diseases (36.4%). Commonly mentioned sub-features in 72.7% of the studies identified motivation and trust attributes as desirable, 36.4% highlighting synchronism of technology, adaptability of App with different mobile-phones recorded in 45.5% of the studies while 63.6% value the fit-for-purpose attribute. These features were cited as desirable with little evidence of the geo-social influence of the users nor socio-economic setting.</p> <p><strong>Conclusion:</strong>The study exposed the HcPs’ perceptions to the mobile-technology attributes as customised requirements, process requirements, moderating information-technology constructs and intervening &amp; dependent requirements. Geospatial setting and income status of the country are less important in shaping the perceptions of HcPs as users of the mobile-technology.</p> 2018-12-01T00:00:00+00:00 ##submission.copyrightStatement## Endoscopic or minimally invasive surgical approach for infected necrotizing pancreatitis: a systematic review and meta-analysis. 2018-12-12T07:57:14+00:00 Yong Hu Chunyan Li Xin Zhao Yunfeng Cui <p><strong>Background and Aim</strong>: The incidence of acute pancreatitis is rising around the world, thus further increasing the burden on healthcare services. Approximately 10% of patients with acute pancreatitis will develop infected necrotizing pancreatitis, which is the leading cause of high mortality in the late phase. There is currently no consensus with regard to the use of endoscopic or minimally invasive surgical as the first-line therapy of choice for infected necrotizing pancreatitis. However, more clinical research regarding the superiority of the endoscopic approach has been published recently. Therefore, we conducted a systematic review and meta-analysis to determine which of the two treatments leads to a better prognosis.</p> <p><strong>Methods:</strong> Four databases (Medline, SinoMed, EMBASE, and Cochrane Library) were searched for eligible studies from 1980 to 2018 comparing endoscopic and minimally invasive surgical for infected necrotizing pancreatitis.</p> <p><strong>Results:</strong> Two RCTs and seven clinical cohort studies were included. After the analysis of data amenable to polling, significant advantages were found in favor of the endoscopic approach in terms of pancreatic fistula (OR=0.10, 95%CI 0.04–0.30, P&lt;0.001)and length of hospital stay (WMD=–24.72, 95%CI=–33.87 to –15.57, P&lt;0.001). No marked differences were found in terms of mortality, multiple organ failure, intra-abdominal bleeding, enterocutaneous fistula, recurrence of pseudocysts, length of stay in the ICU, endocrine insufficiency and exocrine insufficiency.</p> <p><strong>Conclusion: </strong>Compared with minimally invasive surgical, endoscopic remedy evidently improved short-term outcomes for infected necrotizing pancreatitis, including pancreatic fistula and length of hospital stay. Furthermore, relevant multicenter RCTs are eager to prove these findings.</p> 2018-12-12T07:57:14+00:00 ##submission.copyrightStatement##